May 15, 2018 08:38 AM EDT
People
Financing

High pro­file biotech in­vestor Beth Sei­den­berg is ex­it­ing Klein­er Perkins and start­ing her own fund — re­port

John Carroll

Editor & Founder

Beth Sei­den­berg is jump­ing out of her high pro­file role as a gen­er­al part­ner at Klein­er Perkins to start her own life sci­ences fund. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

A service from the Financial Times